Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.
Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J, Sieper J. Song IH, et al. Among authors: heldmann f. Arthritis Rheum. 2010 May;62(5):1290-7. doi: 10.1002/art.27383. Arthritis Rheum. 2010. PMID: 20461780 Clinical Trial.
Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis.
Tran-Duy A, Nguyen TT, Thijs H, Baraliakos X, Heldmann F, Braun J, Boonen A. Tran-Duy A, et al. Among authors: heldmann f. Arthritis Care Res (Hoboken). 2015 Nov;67(11):1578-85. doi: 10.1002/acr.22655. Arthritis Care Res (Hoboken). 2015. PMID: 26216525 Free article. Clinical Trial.
Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
Braun J, Kiltz U, Heldmann F, Baraliakos X. Braun J, et al. Among authors: heldmann f. Expert Opin Emerg Drugs. 2015 Mar;20(1):1-14. doi: 10.1517/14728214.2015.993378. Epub 2015 Jan 9. Expert Opin Emerg Drugs. 2015. PMID: 25575936 Review.
Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.
Braun J, Kiltz U, Sarholz M, Heldmann F, Regel A, Baraliakos X. Braun J, et al. Among authors: heldmann f. Expert Rev Clin Immunol. 2015;11(8):935-46. doi: 10.1586/1744666X.2015.1052795. Epub 2015 Jun 5. Expert Rev Clin Immunol. 2015. PMID: 26048334 Review.
Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.
Baraliakos X, Haibel H, Fritz C, Listing J, Heldmann F, Braun J, Sieper J. Baraliakos X, et al. Among authors: heldmann f. Arthritis Res Ther. 2013;15(3):R67. doi: 10.1186/ar4244. Arthritis Res Ther. 2013. PMID: 23786760 Free PMC article. Clinical Trial.
Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?
Kiltz U, Heldmann F, Baraliakos X, Braun J. Kiltz U, et al. Among authors: heldmann f. Curr Opin Rheumatol. 2012 May;24(3):252-60. doi: 10.1097/BOR.0b013e3283524b82. Curr Opin Rheumatol. 2012. PMID: 22450391 Review.
One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare.
Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Haug-Rost I, Braun J, Sieper J. Song IH, et al. Among authors: heldmann f. Ann Rheum Dis. 2013 Feb;72(2):305-6. doi: 10.1136/annrheumdis-2012-201926. Epub 2012 Aug 11. Ann Rheum Dis. 2013. PMID: 22887847 Clinical Trial. No abstract available.
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
Heldmann F, Baraliakos X, Kiltz U, Brandt J, van der Horst-Bruinsma IE, Landewé R, Sieper J, Burmester GR, van den Bosch F, de Vlam K, Gaston H, Gruenke M, Witt M, Appelboom T, Emery P, Dougados M, Leirisalo-Repo M, Breban M, Braun J. Heldmann F, et al. Clin Exp Rheumatol. 2016 Mar-Apr;34(2):184-90. Epub 2016 Mar 25. Clin Exp Rheumatol. 2016. PMID: 27049733
Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference?
Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J. Braun J, et al. Among authors: heldmann f. J Rheumatol. 2015 Jan;42(1):31-8. doi: 10.3899/jrheum.130959. Epub 2014 Nov 15. J Rheumatol. 2015. PMID: 25399389 Review.
Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.
Braun J, Baraliakos X, Heldmann F, Kiltz U. Braun J, et al. Among authors: heldmann f. Expert Opin Investig Drugs. 2014 May;23(5):647-59. doi: 10.1517/13543784.2014.899351. Epub 2014 Mar 22. Expert Opin Investig Drugs. 2014. PMID: 24654630 Review.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback